To confirm the connection between copy number variants and the methylation of DNAH17, we used the TaqMan copy number assays to assess the copy number status of DNAH17 in our cohort and found the copy number was increased in 30.8% HCC samples when compared to ANT (Figure 4B). Here, DNAH17 is linked to hepatocellular carcinoma.